AstraZeneca prices a $5bn bond offering
22 February 2024 07:00 GMT AstraZeneca prices a $5bn bond offering AstraZeneca PLC ("AstraZeneca") announces that its wholly owned subsidiary AstraZeneca Finance LLC, priced a four tranche global bond offering totalling $5bn on 21 February 2024. The offering is expected to close on 26 February 2024, subject to customary closing conditions. The transaction, which is a global offering registered with the US Securities and Exchange Commission ("SEC"), consists of the following four tranches: Notes issued by AstraZeneca Finance LLC and fully and unconditionally guaranteed by